E009-1035 Screening compound: N-[(4-fluorophenyl)methyl]-1-{[1-phenyl-5-(1H-pyrrol-1-yl)-1H-pyrazol-4-yl]methyl}piperidine-3-carboxamide

E009-1035 Screening compound: N-[(4-fluorophenyl)methyl]-1-{[1-phenyl-5-(1H-pyrrol-1-yl)-1H-pyrazol-4-yl]methyl}piperidine-3-carboxamide
E009-1035 Screening compound: N-[(4-fluorophenyl)methyl]-1-{[1-phenyl-5-(1H-pyrrol-1-yl)-1H-pyrazol-4-yl]methyl}piperidine-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E009-1035
N-[(4-fluorophenyl)methyl]-1-{[1-phenyl-5-(1H-pyrrol-1-yl)-1H-pyrazol-4-yl]methyl}piperidine-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E009-1035

Molecular Formula

C27H28FN5O (C27 H28 FN5 O)

Compound Name

N-[(4-fluorophenyl)methyl]-1-{[1-phenyl-5-(1H-pyrrol-1-yl)-1H-pyrazol-4-yl]methyl}piperidine-3-carboxamide

IUPAC name

N-[(4-fluorophenyl)methyl]-1-{[1-phenyl-5-(1H-pyrrol-1-yl)-1H-pyrazol-4-yl]methyl}piperidine-3-carboxamide

SMILES

O=C(C1CN(Cc2c(-n3cccc3)n(-c3ccccc3)nc2)CCC1)NCc(cc1)ccc1F

InChI

InChI=1S/C27H28FN5O/c28-24-12-10-21(11-13-24)17-29-26(34)22-7-6-14-31(19-22)20-23-18-30-33(25-8-2-1-3-9-25)27(23)32-15-4-5-16-32/h1-5,8-13,15-16,18,22H,6-7,14,17,19-20H2,(H,29,34)/t22-/m0/s1

InChI Key

ZRJGWLOAOYUAJA-QFIPXVFZSA-N

MDL Number (MFCD)

MFCD14837075

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

457.55

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.953

Distribution Coefficient, logD

2.129

Water Solubility, LogSw

-3.76

Polar Surface Area

45.174

Acid Dissociation Constant (pKa)

11.52

Base Dissociation Constant (pKb)

9.22

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

25.90

E009-1035 in Drug Discovery

Included in Screening Libraries

CNS Targets (44014 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

SH2 Library (10483 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Nervous system
  • Cancer
  • Endocrine
Targets:
  • GPCR
  • Ion Channels
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with E009-1035 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E009-1035?
Check Price and Availability of E009-1035, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E009-1035 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E009-1035
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E009-1035
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E009-1035 available by request